NN, Inc. Reports First Quarter 2025 Results

In This Article:

NN, Inc.
NN, Inc.

Company reaffirms full-year adjusted EBITDA 2025 outlook and five-year sales and margin targets

Company initiates full-year 2025 free cash flow guidance of $14-$16 million

CHARLOTTE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported results for the first quarter ended March 31, 2025.

First Quarter Highlights

  • Net sales of $105.7 million, decreased by 12.8% versus the prior year first quarter.

  • Pro forma net sales, adjusted for the sale of Lubbock, rationalized business, and currency translation, decreased by 1.3% compared to the prior year first quarter.

    • Strong China domestic sales growth continues, up by 12.5% versus the prior year first quarter.

    • NN does not directly sell Chinese manufactured products into the U.S.

  • GAAP earnings per share of $(0.23) and adjusted earnings per share results of $(0.03), increases versus ($0.34) and ($0.08), respectively, versus the prior year first quarter.

  • Pro forma adjusted EBITDA of $10.6 million, flat to prior year first quarter.

  • Adjusted EBITDA margin of 10%, an increase compared to 9.3% in the prior year first quarter.

  • NN is tracking to all long-term goals and transformational pillars - growth, diversification, costs, and cash.

  • Recently raised 5-year adjusted EBITDA margin target to 13-14%.

    • Rationalization of underperforming business and plants remains on track with additional footprint reductions under evaluation; an estimated $15 million total cost savings are expected in 2025.

  • New business wins were $16.4 million, concentrated in the key focus areas of industrial products, electrical and power products, medical, and high-value automotive products.

    • NN’s new business pipeline remains robust at over $740 million and continues to expand in key targeted growth areas. Approximately 30% of the pipeline focused on non-traditional automotive applications.

    • NN’s pipeline and new business wins are improving sales and margin mix and strengthening the Company’s sales growth and structural earnings power.

  • Medical products business growth plan stays focused; currently adding specialized equipment to meet expanded new business pipeline and support initial wins. NN’s medical pipeline is currently at peak levels of $40+ million since re-entering the medical market in October 2023.

  • Term Loan refinancing process completed post quarter-end, positioning the Company to advance its 5-year transformation plans.

“NN marked another quarter of solid steps forward across key areas of our transformation, and our results for the quarter have kept us on track with our full-year outlook and five-year plan. Our strategic and transformation-led progress was highlighted by growth and new wins in targeted markets, including stamped, medical, and electrical products, as well as high-value automotive” said Harold Bevis, President and Chief Executive Officer of NN, Inc. “Our commercial growth agenda captured $16.4 million of new business wins in the quarter, progress that has kept the Company on pace to meet its aggressive multi-year sales growth target.